Innoforce is a partnership-focused biopharmaceutical company established to enable and accelerate the innovation of breakthrough medicines. The company has world-class biopharmaceutical manufacturing and development capabilities to serve global markets at our campus in Hangzhou, China, and offices in Rockville, Maryland. Innoforce offers end-to-end contract development and manufacturing service (CDMO), including GMP manufacturing of plasmid DNA, RNA, viral vector, and cell products by the middle of 2022. In addition, through a joint venture with a leading international supplier of life sciences products & services, the company provides CDMO services for antibody and protein drugs. Innoforce's enabling capabilities for incubating and developing cell, gene, and advanced biological therapies can support partners and portfolio companies to rapidly and efficiently bring cutting-edge treatments that impact patients' lives worldwide. More information is available at www.innoforcepharma.com. Innoforce Contact: Ken Carter Head of Global Corporate Development Phone: +1 240-421-3838 E-mail: ken.carter@innoforcepharma.com Website: www.innoforcepharma.com SOURCE Innoforce Pharmaceuticals